MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202641111721 A) filed by Saveetha Institute Of Medical And Technical Sciences on September 17, 2026, for Ai-Assisted Clinical Decision Support Tool For Genetic Risk Assessment.
Inventors include A. Chandrahas Reddy; Dr. C. Sivasankar; Dr. Rithika Srinivasan; and Dr Ramya Mohan.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The AI-Based Genetic Risk Assessment Tool is a healthcare-focused application designed to help both clinicians and individuals understand potential genetic risks using structured patient or user data. The system collects family medical history, demographic details, and basic lifestyle factors to evaluate inherited risk patterns. Using a combination of AI-assisted and rule-based analysis, the tool categorizes users into low, moderate, or high genetic risk groups, supporting preventive care planning, early screening decisions, and personal health awareness. The system does not perform diagnosis or treatment but serves as a decision support and educational aid, improving consistency and efficiency in genetic risk evaluation. The application provides explainable insights, helping users and clinicians understand the factors contributing to the assessed risk level. Secure authentication, encrypted data storage, and ethical data-handling practices ensure privacy and compliance with healthcare standards. Overall, the system enhances workflow and personal health management by simplifying genetic risk assessment, supporting informed decision-making, and promoting preventive healthcare through a transparent, AI-assisted, and user-friendly approach.
Disclaimer: Curated by HT Syndication.
